ArticleImmunoHorizons2019

Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes.

Jennifer Schloss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.